Takeda to supply 50 mil. coronavirus vaccine doses in Japan in 2021

Takeda Pharmaceutical Co. said Thursday it plans to supply 50 million doses of a coronavirus vaccine, developed by U.S. drugmaker Moderna Inc., in Japan from the first half of next year.The Japanese drugmaker said it will provide the vaccine based on a three-way agreement with Moderna and the Ministry of Health, Labor and Welfare once the vaccine has been approved.Takeda said Moderna's Phase 3 clinical trial has completed enrollment of 30,000 participants in the United States. The health ministry said the doses of the vaccine to be distributed by Takeda will cover 25 million people in Japan…READ FULL ARTICLE